Literature DB >> 23585246

The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome.

Jee-Young Oh1, Yeon-Ah Sung, Hye Jin Lee.   

Abstract

OBJECTIVE: Visceral fat accumulation is more strongly related to insulin resistance than to excess total adiposity. The visceral adiposity index (VAI) has recently been suggested as an indicator of the visceral adiposity measured by magnetic resonance imaging. To evaluate whether the VAI could replace visceral computed tomography (CT) scanning and predict insulin resistance in young women with polycystic ovary syndrome (PCOS) was presented. DESIGN AND METHODS: One hundred and eighty Korean women aged 16-41 years who were diagnosed with PCOS using the Rotterdam criteria were included. The VAI was derived from a formula using body mass index, waist circumference, triglycerides, and high-density lipoprotein cholesterol. Visceral adiposity was defined as a visceral fat area (VFA) measuring > 100 cm(2) by CT scanning. Insulin sensitivity was evaluated by insulin-mediated glucose utilization (M value), which was obtained using a euglycemic hyperinsulinemic clamp.
RESULTS: The VAI positively correlated with VFA, the visceral-to-subcutaneous fat ratio, and systolic and diastolic blood pressure, and negatively correlated with the M value. In a linear regression analysis, the VAI was an independent determinant of the insulin sensitivity after controlling for age, systolic blood pressure, fasting glucose, fasting insulin, and testosterone levels. In a logistic regression analysis, the VAI odds ratio was 3.5 (95% CI 1.2-9.8) for predicting visceral adiposity after controlling for the various metabolic parameters and testosterone.
CONCLUSION: The VAI can replace visceral CT scanning as a marker for visceral adiposity, and it predicts insulin resistance in young women with PCOS.
Copyright © 2013 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23585246     DOI: 10.1002/oby.20096

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  37 in total

1.  Is prolactin the missing link in adipose tissue dysfunction of polycystic ovary syndrome patients?

Authors:  Alice Albu; Suzana Florea; Simona Fica
Journal:  Endocrine       Date:  2015-06-12       Impact factor: 3.633

2.  Design and validation of a novel estimator of visceral adipose tissue area and comparison to existing adiposity surrogates.

Authors:  Pandora L Wander; Tomoshige Hayashi; Kyoko Kogawa Sato; Shinichiro Uehara; Yonezo Hikita; Donna L Leonetti; Steven E Kahn; Wilfred Y Fujimoto; Edward J Boyko
Journal:  J Diabetes Complications       Date:  2018-09-11       Impact factor: 2.852

3.  Visceral adiposity index (VAI), a powerful predictor of incident hypertension in prehypertensives.

Authors:  Teresa Vanessa Fiorentino
Journal:  Intern Emerg Med       Date:  2018-04-26       Impact factor: 3.397

4.  Visceral adiposity index, hypertriglyceridemic waist phenotype and chronic kidney disease in a southern Chinese population: a cross-sectional study.

Authors:  Jun Huang; Chaomin Zhou; Yongqiang Li; Shuangshuang Zhu; Aiqun Liu; Xiaofei Shao; Xinyu Liu; Harry Holthfer; Hequn Zou
Journal:  Int Urol Nephrol       Date:  2015-07-07       Impact factor: 2.370

5.  Potential influence of the phthalates on normal liver function and cardiometabolic risk in males.

Authors:  Nataša Milošević; Nataša Milić; Dragana Živanović Bosić; Ivana Bajkin; Ivanka Perčić; Ludovico Abenavoli; Milica Medić Stojanoska
Journal:  Environ Monit Assess       Date:  2017-12-13       Impact factor: 2.513

6.  Visceral adiposity index (VAI), a powerful predictor of incident hypertension in prehypertensives.

Authors:  Zhipeng Zhang; Di Shi; Qiang Zhang; Si Wang; Kai Liu; Qingtao Meng; Xiaoping Chen
Journal:  Intern Emerg Med       Date:  2018-03-22       Impact factor: 3.397

7.  Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.

Authors:  U Durmus; C Duran; S Ecirli
Journal:  J Endocrinol Invest       Date:  2016-11-12       Impact factor: 4.256

8.  Predictive value of visceral adiposity index for type 2 diabetes mellitus: A 15-year prospective cohort study.

Authors:  Y Wang; S He; J He; S Wang; K Liu; X Chen
Journal:  Herz       Date:  2014-11-21       Impact factor: 1.443

9.  Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.

Authors:  Uche Ezeh; Marita Pall; Ruchi Mathur; Ricardo Azziz
Journal:  Hum Reprod       Date:  2014-05-09       Impact factor: 6.918

10.  Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009.

Authors:  T Du; X Sun; R Huo; X Yu
Journal:  Int J Obes (Lond)       Date:  2013-09-19       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.